No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
94 |
4. Check minimum number of eventsNone |
94 |
5. Include endpointsNone |
94 |
6. Filter based on genotype QC (FinnGen only) |
94 |
Control definitions (FinnGen only)
- Control exclude
- Q17_CONGEN_MALFO_DEFORMAT_MUSCULOS_SYSTEM
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- Q6[5-9]|Q7
- Name in latin
- Defectus reductionales membri inferioris
Similar endpoints
↥List of similar endpoints to
Reduction defects of lower limb
based on the number of shared cases.
Similar with more cases:
- Congenital malformations and deformations of the musculoskeletal system
- Congenital malformations, deformations and chromosomal abnormalities
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 1123 | 543 | 577 |
| Only index persons | 1005 | 493 | 512 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.02 | 0.02 | 0.02 |
| Only index persons | 0.02 | 0.02 | 0.02 |
| Median age at first event (years) | |||
| Whole population | 13.45 | 13.58 | 13.09 |
| Only index persons | 13.87 | 14.04 | 13.71 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 94 | 54 | 40 |
| Unadjusted period prevalence (%) | 0.02 | 0.02 | 0.02 |
| Median age at first event (years) | 22.25 | 27.72 | 14.86 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 85
- Matched controls
- 851
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
Q72.88
ICD-10 Finland
Other reduction defects of lower himb(s)
+∞
50.0
43
*
Q72.9
ICD-10 Finland
Reduction defect of lower limb, unspecified
+∞
21.8
20
*
M21.7
ICD-10 Finland
Unequal limb length (acquired)
112.0
9.6
10
*
NFU20
NOMESCO Finland
Removal of internal fixation device from femur
49.7
7.9
9
*
Z3231
NOMESCO Finland
Registered nurse
3.5
6.3
36
149
TNX33
NOMESCO Finland
Custom moulded cast, unspecified region
11.3
6.2
11
11
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
30
141
2.66
4.32
1.8
2.4
mg/l
1.4
0.9
0.51
21
102
(3021589) Normoblasts [#/volume] in Blood
51
339
2.10
3.11
8.7
7.7
e9/l
0.0
0.0
0.49
46
273
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
13
46
3.12
3.06
1.5
1.5
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
17
72
2.66
2.93
2.0
1.8
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
27
148
2.16
2.65
1.6
1.5
—
—
—
0
0
(3000991) Gas panel - Venous blood
11
39
3.06
2.57
25.4
14.6
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
18
85
2.38
2.48
2.2
2.0
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
14
59
2.61
2.43
5.4
4.5
%
0.0
0.5
—
5
15
(3024561) Albumin [Mass/volume] in Serum or Plasma
39
252
1.94
2.42
4.4
5.0
g/l
37.8
37.0
0.40
30
240
(3017181) Myelocytes/100 leukocytes in Blood
15
66
2.51
2.39
5.1
4.2
%
2.2
1.0
—
5
21
(3021440) Promyelocytes/100 leukocytes in Blood
14
60
2.57
2.35
5.3
4.4
%
0.2
0.2
—
5
18
(3004588) Protein electrophoresis panel - Serum or Plasma
9
30
3.21
2.21
1.6
3.7
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
26
152
1.98
2.12
3.2
4.0
—
—
—
0
0
(1002224) Polysomnography panel
10
39
2.75
1.99
1.1
1.1
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
8
27
3.14
1.98
1.8
1.9
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
6
16
3.93
1.97
1.3
1.6
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
35
232
1.81
1.94
1.6
1.8
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
6
17
3.69
1.87
1.3
1.6
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
14
68
2.24
1.81
1.6
1.3
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
18
99
2.01
1.72
2.0
1.7
—
—
—
0
0
(3044889) 12 lead EKG panel
58
459
1.69
1.64
3.4
3.0
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
6
21
2.98
1.53
1.2
1.1
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
29
196
1.69
1.46
4.9
2.8
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
6
22
2.84
1.46
13.2
4.5
kpa
10.3
8.8
—
6
22
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
6
22
2.84
1.46
5.0
3.5
%
1.2
1.2
—
6
22
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
45
343
1.60
1.41
5.2
4.0
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
38
0.00
1.38
0.0
1.5
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
5
17
3.05
1.37
2.6
2.8
%
56.4
60.3
—
5
17
(3016650) Hepatitis A virus Ab [Presence] in Serum
5
17
3.05
1.37
1.0
1.1
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
32
226
1.63
1.35
8.3
6.5
—
—
—
0
0
(4010399)
9
43
2.21
1.34
1.1
1.5
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
6
26
2.39
1.20
1.5
5.6
g/l
4.1
3.7
—
6
26
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
18
112
1.75
1.20
6.1
3.6
ng/l
33.2
99.8
—
10
70
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
38
290
1.52
1.13
4.3
2.4
nmol/l
72.7
71.7
0.13
33
261
(3007164) IgA [Mass/volume] in Serum or Plasma
28
200
1.57
1.11
1.5
1.4
g/l
2.1
2.1
0.05
21
128
(3022313) Gas panel - Capillary blood
7
32
2.28
1.10
12.7
5.5
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
10
53
1.99
1.06
1.4
1.7
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
22
150
1.61
1.05
3.8
2.0
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
5
22
2.34
1.04
1.6
1.2
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
21
292
0.64
0.99
1.7
2.2
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
37
289
1.46
0.96
2.2
2.2
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
8
137
0.55
0.92
1.1
1.6
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
6
29
2.14
0.91
1.3
1.7
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
6
29
2.14
0.91
1.0
1.6
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
28
209
1.48
0.90
3.6
2.0
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
13
80
1.73
0.90
1.2
1.4
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
13
80
1.73
0.90
1.1
1.4
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
13
80
1.73
0.90
1.1
1.4
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
61
529
1.44
0.87
8.4
7.0
u/l
78.1
74.2
0.50
61
503
(3028300) Cannabinoids [Presence] in Urine
13
81
1.70
0.86
1.1
1.4
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
6
31
2.00
0.86
51.8
5.1
mmol/l
27.2
24.6
—
6
31
(3018418) pH of Serum or Plasma
25
185
1.48
0.84
7.3
4.2
ph
7.4
7.4
—
5
32
(3013139) Helicobacter pylori Ag [Presence] in Stool
8
48
1.73
0.81
1.3
1.2
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
11
67
1.73
0.79
1.5
1.7
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
11
67
1.73
0.79
1.9
1.5
—
—
—
0
0
(3012544) pH of Venous blood
9
53
1.77
0.78
13.0
5.8
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
5
23
2.24
0.77
1.6
1.7
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
9
54
1.74
0.77
1.2
1.2
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
29
225
1.42
0.76
2.2
1.8
pmol/l
99.6
96.7
0.15
14
113
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
5
24
2.14
0.76
1.6
1.7
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
5
24
2.14
0.76
1.2
1.8
—
—
—
0
0
(3000492) Spirometry study
11
68
1.70
0.75
1.3
1.2
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
7
38
1.91
0.75
1.1
1.6
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
12
77
1.64
0.72
1.1
1.4
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
7
43
1.68
0.68
1.3
1.8
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
10
62
1.69
0.68
1.1
1.5
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
27
211
1.39
0.68
1.6
3.2
mmol/l
2.3
2.3
1.31
22
184
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
81
755
1.53
0.67
19.3
11.2
mg/l
22.7
21.0
0.20
63
568
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
6
102
0.56
0.66
2.8
2.2
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
7
44
1.64
0.66
29.1
11.9
mmol/l
7.0
7.4
—
7
44
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
14
96
1.54
0.66
1.9
2.1
mmol/l
2.4
2.4
—
6
80
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
5
30
1.70
0.62
1.4
5.5
%
77.0
97.5
—
5
30
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
8
124
0.61
0.59
2.6
2.3
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
14
99
1.49
0.58
1.7
2.2
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
13
94
1.44
0.49
2.8
2.7
umol/l
12.5
14.8
0.56
13
87
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
27
223
1.30
0.47
1.4
1.3
u/ml
0.6
1.2
—
8
55
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
17
131
1.36
0.46
1.3
1.3
u/ml
8.2
4.9
—
8
55
(3021879) Hepatitis B virus core Ab [Presence] in Serum
12
87
1.43
0.45
1.3
1.4
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
5
31
1.65
0.44
1.4
1.1
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
74
696
1.30
0.41
12.4
9.5
ml/min/173m2
98.1
94.6
0.69
65
550
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
0
16
0.00
0.41
0.0
1.2
—
119.9
—
0
16
(4306422)
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
0
16
0.00
0.41
0.0
2.7
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
0
17
0.00
0.41
0.0
1.1
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
0
17
0.00
0.41
0.0
1.0
—
1.5
—
0
6
(3026782) Osmolality of Urine
16
125
1.34
0.40
6.1
2.4
mosm/kgh2o
500.8
547.5
0.32
16
109
(3050129) First trimester maternal screen panel - Serum or Plasma
9
66
1.40
0.40
1.2
1.5
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
84
805
1.41
0.39
15.5
10.0
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
24
200
1.27
0.39
1.8
2.2
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
29
248
1.24
0.38
1.9
1.7
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
25
212
1.24
0.35
5.2
3.0
ng/l
16.7
29.3
0.76
15
118
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
13
163
0.77
0.33
1.2
1.4
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
7
52
1.37
0.32
1.4
1.5
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
7
52
1.37
0.32
1.4
1.5
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
7
55
1.29
0.31
1.4
1.6
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
41
371
1.19
0.30
7.1
4.8
estimate
0.0
0.0
0.00
15
75
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
8
64
1.27
0.28
1.0
1.0
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
26
295
0.84
0.28
6.5
3.3
—
—
—
0
0
(3022145) Colonoscopy Study observation
9
72
1.28
0.26
1.4
1.3
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
52
484
1.17
0.26
6.7
4.4
—
31.4
—
0
11
(3035350) Ketones [Presence] in Urine by Test strip
41
376
1.16
0.25
4.9
3.4
estimate
0.0
0.0
0.00
15
73
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
25
220
1.19
0.24
1.8
2.4
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
10
124
0.78
0.23
1.0
1.3
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
10.6
—
0.6
—
0
10
(3039443) Prostate specific Ag panel - Serum or Plasma
0
10
0.00
0.21
0.0
1.6
—
—
—
0
0
(3005082) Progesterone [Moles/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.2
—
29.5
—
0
12
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
18.1
—
1498.0
—
0
12
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
0
13
0.00
0.21
0.0
1.2
—
94.3
—
0
13
(3008757) Leukocyte morphology finding [Identifier] in Blood
0
13
0.00
0.21
0.0
3.4
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
24
268
0.86
0.21
1.9
1.7
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
0
14
0.00
0.20
0.0
1.0
—
1.1
—
0
5
(3023430) Cat dander IgE Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.1
—
10.5
—
0
5
(3009261) Glucose [Presence] in Urine by Test strip
41
381
1.13
0.20
5.0
3.4
estimate
0.0
0.0
0.00
15
71
(3019832) Treponema pallidum Ab [Presence] in Serum
21
186
1.17
0.19
1.7
1.9
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
17
194
0.85
0.19
8.0
2.8
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
20
177
1.17
0.18
8.2
4.6
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
26
236
1.14
0.17
4.1
6.1
inr
0.9
1.1
—
7
78
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
9
78
1.17
0.16
3.6
4.0
umol/l
5.0
12.6
—
9
66
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
9
79
1.15
0.16
5.6
6.5
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
9
80
1.14
0.15
1.7
1.2
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
27
250
1.11
0.13
6.6
3.5
e6/l
12.7
36.6
0.78
16
176
(3011397) Hemoglobin [Presence] in Urine by Test strip
18
163
1.13
0.12
2.5
3.5
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
10
86
1.18
0.11
1.6
1.1
—
—
—
0
0
(40758558) Short blood count panel - Blood
20
183
1.12
0.11
8.4
7.0
—
—
—
0
0
(4035726)
5
45
1.12
0.10
1.2
1.4
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
68
663
1.09
0.09
3.4
3.8
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
12
107
1.14
0.09
3.8
2.5
e6/l
2.7
2.5
—
7
58
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
58
563
1.08
0.09
4.2
3.8
pmol/l
14.6
14.6
0.05
52
518
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
7
68
1.03
0.08
1.6
1.6
—
—
—
0
0
(3002256) Pathology report gross observation
8
76
1.06
0.07
1.3
1.1
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
17
157
1.10
0.07
3.4
3.8
mg/mmol
12.1
11.2
0.03
12
103
(3048689) Calprotectin [Mass/mass] in Stool
15
138
1.10
0.07
1.9
2.0
ug/g
91.1
86.9
—
10
106
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
10
109
0.91
0.04
1.4
1.6
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
25
242
1.05
0.02
1.8
1.6
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
21
203
1.04
0.01
5.3
3.4
estimate
0.0
0.0
0.00
14
73
(3037467) Urinalysis macro (dipstick) panel - Urine
51
517
0.97
0.01
8.2
4.2
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
74
743
0.98
0.00
20.3
12.2
%
41.1
41.4
0.13
59
616
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
23
233
0.98
0.00
6.5
3.2
—
—
—
0
0
(3015736) pH of Urine
29
293
0.99
0.00
4.5
3.2
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
23
225
1.03
0.00
6.7
2.8
—
—
—
0
0
(3013512) EKG study
15
146
1.03
0.00
3.8
3.2
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
11
115
0.95
0.00
3.9
2.5
e6/l
0.2
0.7
—
6
65
(3002582) Erythrocytes [#/volume] in Urine
21
214
0.98
0.00
6.9
2.9
e6/l
23.7
48.1
0.39
16
168
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
8
0.00
0.00
0.0
2.6
—
—
—
0
0
(4281824)
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
0
5
0.00
0.00
0.0
3.6
—
68.5
—
0
5
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
6
61
0.98
0.00
1.5
1.6
—
—
—
0
0
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
2.9
—
56.7
—
0
7
(3032773) Endomysium IgG Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
6
61
0.98
0.00
1.5
1.6
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
5
50
1.00
0.00
1.2
1.6
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
2.0
—
3.3
—
0
7
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
132.3
—
0
6
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
6
61
0.98
0.00
1.5
1.6
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
6
61
0.98
0.00
1.5
1.6
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
2.9
—
145.7
—
0
7
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(21491868) Cryoglobulin [Mass/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
9.7
—
0
5
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004451) EKG impression Narrative
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
6
63
0.95
0.00
1.2
1.4
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
8
0.00
0.00
0.0
2.6
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
7.6
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
2.2
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3019225) pH of Specimen
5
56
0.89
0.00
2.2
4.4
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3036782) Glucose [Moles/volume] in Pleural fluid
0
5
0.00
0.00
0.0
1.0
—
7.4
—
0
5
(3041806) Other cells [#/volume] in Blood by Manual count
0
8
0.00
0.00
0.0
1.9
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint Q17_REDUCT_DEFECTS_LOWER_LIMB and mortality.
Females
No dataMales
No dataMortality risk
Mortality risk for people of age
years, who have Q17_REDUCT_DEFECTS_LOWER_LIMB.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | No data |
| 5 | No data | No data |
| 10 | No data | No data |
| 15 | No data | No data |
| 20 | No data | No data |
Relationships between endpoints
↥Index endpoint: Q17_REDUCT_DEFECTS_LOWER_LIMB – Reduction defects of lower limb
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data